Posters
« Back
Improved T Cell Activation Bioassays for Development of Bispecific Antibodies and Engineered T Cell Immunotherapies
EP25778
Improved T Cell Activation Bioassays for Development of Bispecific Antibodies and Engineered T Cell Immunotherapies
Submitted on 15 May 2017

Pete Stecha, Denise Garvin, Jim Hartnett, Frank Fan, Mei Cong and Zhi-jie Jey Cheng
Promega Corporation, 2800 Woods Hollow Rd, Madison, WI 53711
Poster Views: 168
View poster »
Poster Abstract
Immunotherapy aims to boost a patient’s own immune system to fight disease. In recent years, a variety of immunotherapy strategies aimed at inducing, strengthening or engineering T cell responses have emerged as promising approaches for the treatment of cancer and autoimmune disease.

Here we describe a platform of T cell activation bioassays for the development of CD3 bispecific antibodies and engineered T cell immunotherapies.

Specifically, we developed two bioluminescent reporter-based bioassays to measure T cell activation via CD3 (NFAT-RE) or CD3 + CD28 (IL-2 promoter). These

Corresponding author: richard.somberg@promega.comReport abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


Immunotherapy on Chip: “Under the Microscope” Drug-induced Modulation of the Immune Response
A. De Ninno (a), F. Bertani (a), A. Gerardino (a), F. Mattei (b), V. Lucarini (b), G. Schiavoni (b), S. Parlato (b), L. Gabriele (b), R. Molfetta (f), E. Martinelli (c), A. Mencattini (c), D. Di Giuseppe (c), C. Di Natale (c), G. Kroemer (d), E. Vacchelli (d), A. Rainer (e), S. Giannitelli(e), and L. Businaro(a)

Low-level laser therapy in Russia: history, science and practice
Sergey V. Moskvin

Science Talent Supply Chain Management
Harvey Yau & Mike Berich

Comparison of CD45+ depletion methods for enrichment of disseminated tumor cells in bone marrow samples
Birte Möhlendick1, Imke Hoffmann1, Swetlana Seidschner1, Sarah Schumacher1, Alexander Smyczek1, Carina Vaerst1, Wolfram Trudo Knoefel1, Nikolas Hendrik Stoecklein1

Magnetic-microcontact printing based ECM nano-patterning allows homogeneous controlling of cell growth and behavior
Marc Botcherby1*, Julie Foncy2, Adriana Lagraulet3**, Benjamin Berteloite3**, Aurore Esteve2, Marie-Charline Blatche4, Laurent Malaquin2 & Christophe Vieu2,5